Patients May Not Have Choice in Behavioral Health Visit Modality
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 8, 2023 -- Many patients do not have a choice of whether they receive in-person or remote behavioral health care, according to a report published online Sept. 5 in Health Affairs.
Jessica Sousa, M.P.H., from RAND Corporation in Boston, and colleagues surveyed 2,071 adults (including 571 who used behavioral health services) and conducted semistructured interviews with 26 people with depression or bipolar disorder to explore patients' experiences with visit modality selection.
The researchers found that approximately one-third of patients receiving therapy or medication visits reported that their clinicians did not offer both modalities. In addition, 32 percent reported that they did not typically receive their preferred modality and 45 percent did not believe that their clinician considered their modality preferences. Qualitative findings concurred that some clinicians did not inquire about patients' modality preferences. Perceived lack of choice affected both patient satisfaction and rapport with clinicians and further drove some patients to seek care elsewhere.
"For telehealth to achieve its potential to increase overall access to high-quality, patient-centered care, it is important to implement it in a manner that expands, rather than contracts, behavioral health access and options for patients," Sousa said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.